Toggle Main Menu Toggle Search

Open Access padlockePrints

Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth

Lookup NU author(s): Professor Farhad Kamali, Emeritus Professor Robin Seymour


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Interspecies differences in phenytoin (PHT) metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) were examined in human, cat and rat hepatic microsomes in vitro. Rat liver microsomes were 25 and 650 times more efficient at the conversion of PHT to HPPH than human and cat liver microsomes, respectively. Sulphaphenazole (83%) and tolbutamide (TOL) (64%) were the most potent inhibitors of HPPH formation in human liver microsomes, while ciprofloxacin (27%), enoxacin (27%) and TOL (26%) produced the greatest inhibition in cat liver microsomes. TOL was tested for its effect on HPPH formation and gingival overgrowth in cats in vivo. Eight cats received PHT sodium (4 mg/kg/d) and another 8 cats received PHT sodium together with TOL (20 mg/kg/d) for 10 wk. Six cats (75%) in the PHT group and 4 cats (50%) in the PHT & TOL group developed significant gingival overgrowth by the end of the study. However, the extent and incidence of the overgrowth were similar in the 2 groups. There were no significant differences in mean AUC 0-10weeks for plasma PHT (552.90 ± 29.36 μg·d/mL [PHT alone] vs. 582.41 ± 24.49 μg·d/mL [PHT & TOL]) and unconjugated HPPH (1016.4 ± 295.5 ng·d/mL [PHT alone] vs. 1174.5 ± 397.2 ng·d/mL [PHT & TOL]) concentrations between the 2 groups of cats. Neither PHT nor HPPH were detectable in the plasma of 8 rats which received PHT (4 mg/kg/d) over a 10-wk period. The rats showed no sign of gingival inflammation (mean gingival index = 0) or gingival overgrowth (mean gingival overgrowth index = 0). Thirty-six adult epileptic patients on chronic PHT therapy were examined; 17 (47%) of the patients demonstrated clinically significant overgrowth. The mean steady-state plasma PHT concentration was comparable to, and the mean plasma unconjugated HPPH concentration 5-fold greater than, that observed in the cats. The results suggest that the rapid metabolism and elimination of PHT and HPPH in the rat may enable it to become more resistant towards developing gingival overgrowth, compared to the cat and man.

Publication metadata

Author(s): Kamali F, Ball DE, McLaughlin WS, Seymour RA

Publication type: Article

Publication status: Published

Journal: Journal of Periodontal Research

Year: 1999

Volume: 34

Issue: 3

Pages: 145-153

Print publication date: 01/04/1999

ISSN (print): 0022-3484

ISSN (electronic): 1600-0765

Publisher: Wiley-Blackwell Publishing, Inc.


DOI: 10.1111/j.1600-0765.1999.tb02235.x

PubMed id: 10384402


Altmetrics provided by Altmetric